RYZB - RayzeBio, Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-32.21. This is a potential upside of $-32.21 (0%) from yesterday's end of day stock price of $0.

RayzeBio, Common Stock's activity chart (see below) currently has 6 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 73 days.

Most recent stock forecast was given by JESSICA FYE from JPMORGAN on 28-Dec-2023. First documented stock forecast 10-Oct-2023.

Best performing analysts who are covering RYZB - RayzeBio, Common Stock:

Jessica Fye Robyn Karnauskas

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$30

$-32.49 (-51.99%)

$30

1 years 9 months 27 days ago
(28-Dec-2023)

1/2 (50%)

$-31.67 (-51.35%)

73

Hold

$29

$-33.49 (-53.59%)

$29

1 years 9 months 28 days ago
(27-Dec-2023)

1/2 (50%)

$-32.74 (-53.03%)

73

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RYZB (RayzeBio, Common Stock) average time for price targets to be met?

On average it took 73 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on RYZB (RayzeBio, Common Stock) with a proven track record?

JESSICA FYE

Which analyst has the current lower performing score on RYZB (RayzeBio, Common Stock) with a proven track record?

ROBYN KARNAUSKAS

Which analyst has the most public recommendations on RYZB (RayzeBio, Common Stock)?

Jessica Fye works at JPMORGAN and has 2 price targets and 2 ratings on RYZB

Which analyst is the currently most bullish on RYZB (RayzeBio, Common Stock)?

Jessica Fye with highest potential upside - $-32.49

Which analyst is the currently most reserved on RYZB (RayzeBio, Common Stock)?

Robyn Karnauskas with lowest potential downside - -$33.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?